Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody

被引：95
|
作者：
Yoshizaki, K
Nishimoto, N
Mihara, M
Kishimoto, T
机构：
[1] Osaka Univ, Sch hlth & Sports Sci, Dept Med Sci 1, Suita, Osaka 5650871, Japan
[2] Chugai Pharmaceut Co Ltd, Fuji Gotenba Labs, Shizuoka, Japan
来源：
SPRINGER SEMINARS IN IMMUNOPATHOLOGY | 1998年 / 20卷 / 1-2期
关键词：
D O I：
10.1007/s002810050033
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：247 / 259
页数：13
相关论文
共 50 条
  • [31] ANTI-IL-6 RECEPTOR ANTIBODY (TOCILIZUMAB): A B CELL TARGETING THERAPY
    Toubi, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 152 - 152
  • [32] Anti-IL-6 receptor antibody therapy of a girl with severe systemic juvenile idiopathic arthritis.
    Yamazaki, T
    Agematsu, K
    Tanaka, M
    Nagumo, H
    Yasui, K
    Komiyama, A
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S81 - S81
  • [33] Anti-IL-6 receptor antibody (tocilizumab): a B cell targeting therapy
    Snir, A.
    Kessel, A.
    Haj, T.
    Rosner, I.
    Slobodin, G.
    Toubi, E.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (04) : 697 - 700
  • [34] Anti-IL-6 receptor antibody suppresses the onset of collagen arthritis in monkeys.
    Mihara, M
    Kotoh, M
    Oda, Y
    Kumagai, E
    Takagi, N
    Tsunemi, K
    Takeda, Y
    ARTHRITIS AND RHEUMATISM, 1997, 40 (09): : 613 - 613
  • [35] Anti-IL-6 Receptor Antibody Is Effective In Arthritis Regardless Of Obesity In Mouse Model
    Suzuki, Miho
    Yoshida, Hiroto
    Matsumoto, Yoshihiro
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S540 - S540
  • [36] Anti-IL-6 therapy reduces leptin serum levels in patients with rheumatoid arthritis
    Pulito-Cueto, V
    Remuzgo-Martinez, S.
    Genre, F.
    Calvo-Alen, J.
    Aurrecoechea, E.
    Llorente, I
    Triguero-Martinez, A.
    Blanco, R.
    Llorcas, J.
    Ruiz-Lucea, E.
    Rivera-Garcia, N.
    Gualillo, O.
    Lopez-Mejias, R.
    Castaneda, S.
    Gonzalez-Gay, M. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2020, 38 (06) : 1201 - 1205
  • [37] Effects of anti-IL-6 receptor antibody on human monocytes
    Tono, Toshihiro
    Aihara, Satoko
    Hoshiyama, Takayuki
    Arinuma, Yoshiyuki
    Nagai, Tatsuo
    Hirohata, Shunsei
    MODERN RHEUMATOLOGY, 2015, 25 (01) : 79 - 84
  • [38] Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?
    Ali Berkant Avci
    Eugen Feist
    Gerd R. Burmester
    BioDrugs, 2024, 38 : 61 - 71
  • [39] Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What Have We Learned?
    Avci, Ali Berkant
    Feist, Eugen
    Burmester, Gerd R.
    BIODRUGS, 2024, 38 (01) : 61 - 71
  • [40] Reduction of serum matrix metalloproteinase-3 in rheumatoid arthritis patients following anti-IL-6 receptor antibody therapy.
    Nishimoto, N
    Okada, Y
    Obata, KI
    Matsumoto, T
    Nakahara, H
    Kishimoto, T
    Yoshizaki, K
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S83 - S83
12345